Table 3.
Variable | Univariate linear regression | ||
---|---|---|---|
Regression coefficient | R2 | P value | |
Age | −0.0014 | 0.006 | 0.732 |
Sex (male: 0, female: 1) | −0.179 | 0.138 | 0.081 |
NPDR or PDR (NPDR:0, PDR:1) | 0.272 | 0.394 | 0.001 |
BCVA before treatment | 0.625 | 0.452 | <0.001 |
No. of injections | 0.066 | 0.16 | 0.059 |
Retinal vascular area before treatment | |||
SCP | −0.409 | 0.512 | <0.001 |
DCP | −0.236 | 0.361 | 0.002 |
FAZ (mm2) before treatment | |||
SCP | 0.187 | 0.029 | 0.438 |
DCP | 0.257 | 0.16 | 0.058 |
FAZ (mm2) after treatment | |||
SCP | 0.266 | 0.084 | 0.179 |
DCP | 0.345 | 0.274 | 0.01 |
Retinal vascular area after treatment | |||
SCP | −0.489 | 0.717 | <0.001 |
DCP | −0.274 | 0.618 | <0.001 |
BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; CRT, central retinal thickness; NPDR, nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; SCP, superficial capillary plexus; DCP, deep capillary plexus; FAZ, foveal avascular zone; SD, standard deviation.